Corgenix Announces Termination of Its Proposed Merger With Genesis Bioventures, Inc.

18-Jan-2005

Corgenix Medical Corporation announced that due to the lack of progress towards the completion of the $6 million merger-related financing and the expiration of key dates within the Agreement and Plan of Merger, it has decided to terminate the planned merger with Genesis Bioventures, Inc.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances